Skin Cancer Research
Timothy D. Johnson, M.D., co-director
Andrej A. Dlugosz, M.D., co-director
The Cutaneous Oncology Program consists of clinical and research programs devoted to melanoma and non-melanoma skin cancer.
The Melanoma Multidisciplinary Clinic, designated as the National Cancer Institute's Midwest referral center, offers patients efficient and expedited care regardless of their disease stage. Comprehensive patient care is achieved through the concerted efforts of caretakers from 15 departments or sections, making this one of the most active melanoma clinics in the nation. The Clinic also offers novel melanoma treatment protocols, including gene therapy, adoptive immunotherapy, and combination chemotherapy and immunotherapy. The University of Michigan is a leader in the field of Mohs surgery for the treatment of higher risk basal cell and squamous cell carcinoma, and soft tissue reconstruction of skin cancer defects.
The scientific mission of the Cutaneous Oncology Program is to utilize knowledge gained from basic, preclinical and clinical research endeavors to improve the overall care of patients with skin cancer. We believe that understanding the molecular basis and biology of melanoma and non-melanoma skin cancers will drive future innovations in prevention, diagnosis and treatment. Basic research efforts are focused on areas that have relevance to all forms of cutaneous neoplasia, including the investigation of molecular, biochemical, cellular, and tissue alterations driving the development and progression of skin cancer.